Pharmaceutical Analysis 2019

Aug 02-03, 2019


Chicago, United States of America

2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry

LexisConferences with great pride and honour announcing its 2nd International Conference on Pharmaceutical Analysis & Analytical Chemistry which is going to held in Chicago, USA during August 02-03, 2019. This Conference is mainly focused on the Theme: "New paradigms in Pharmaceutical Analytical Techniques".

Pharmaceutical Analysis 2019 also includes special sessions in workshops, symposiums, one to one meetings special keynote sessions conducted by eminent and renowned speakers who excel in the field of Pharmaceutical Analysis and Drug Discovery, Poster Sessions also available. This International Pharmaceutical Analysis Conference also encourages the active participation of young student researchers as we are hosting Poster Award Competition and Young research Forum at the conference venue. It is a better platform for the pharmaceutical Analysis Graduates to collect and gaining of knowledge from world class Scientists.

This Conference serves as a Stage for the international experts in the area of pharmaceutical analysis and analytical chemistry throughout the world. We cordially invite all the eminent Scientists, researchers, students, industry representatives, Business entrepreneurs & academicians, working in these exciting areas. All come together to Share or explore their Research works and Ideas, Special welcome to the delegates in all fields to gain or gathering of some information for their future.  

Details of Pharmaceutical Analysis 2019 Conference in USA:

           Conference Name



Pharmaceutical Analysis 2019

Chicago, USA

August 02-03, 2019


About the U.S. pharmaceutical analytical testing market, 2014 - 2025 (USD Billion) the global Pharmaceutical Analytical testing market size was valued at USD 4.4 billion in 2015 and it is estimated to grow with CAGR of 8.1% over the forecast period. The pharmaceuticals industry is dominated by the U.S., which holds around 45% of the global market share because it is driven by the regulatory scenario and the presence of well-established outsourcing infrastructure. Leading industry players designate around 20% of their turnover to R&D to maintain a competitive edge.

Program Overview